Prostate cancer: Cabazitaxel-a key therapeutic option in prostate cancer

Nat Rev Urol. 2015 Jun;12(6):312-3. doi: 10.1038/nrurol.2015.98. Epub 2015 May 26.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor
  • Bone Neoplasms / secondary
  • Caenorhabditis elegans Proteins
  • Health Status Indicators
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Prostatic Neoplasms, Castration-Resistant / pathology
  • Quality of Life
  • Taxoids / therapeutic use*
  • Ubiquitin-Conjugating Enzymes

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Caenorhabditis elegans Proteins
  • Taxoids
  • Uev-1 protein, C elegans
  • cabazitaxel
  • Ubiquitin-Conjugating Enzymes